January Therapeutics' Unattributed Round

January Therapeutics raised a round of funding on June 02, 2017.

January Therapeutics is developing next generation targeted anti-cancer therapy. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of …

Articles about January Therapeutics' Unattributed Round: